• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec4
Futuozhidat Listed in Shanghai's New and Excellent Pharmaceutical and Medical Device Catalog
11:35
Nov28
Fosun Tourism Signs Agreements with Multiple Parties, Focuses on Vacation Market
10:41
Nov27
Fosun Group Donates HKD 10 Million for Hong Kong Fire Rescue and Reconstruction
11:54
Nov21
Fosun Pharma's Lumovemetinib for LCH in Children Receives Priority Review for New Indication
09:28
Nov13
Citi Reiterates 'Buy' Rating on Fosun International and Raises Target Price to HK$6.5
04:17
Nov7
Fosun Healthcare Technology and Leo Cancer Care Sign Strategic Cooperation Agreement to Promote Particle Therapy Technology
12:52

Schedules & Filings

Schedules
Filings
Aug27
Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 47.77 B, Net Income 362.19 M, EPS 0.0437

Jul16
Distribution Plan(CST)

Cash dividend 0.02 HKD

Jun12
Distribution Plan(CST)

Cash dividend 0.02 HKD

View More

Stock List

Top Gainers
Top Decliners
Main Board
Symbol
Price
%Chg
Change
01792
0.059
+103.45%
+0.030
02971
0.025
+78.57%
+0.011
08125
0.375
+44.23%
+0.115
01380
0.670
+38.14%
+0.185
01552
0.275
+36.14%
+0.073
08305
0.385
+35.09%
+0.100
01633
0.116
+27.47%
+0.025
00162
0.057
+26.67%
+0.012
01163
0.179
+26.06%
+0.037
02336
0.247
+24.12%
+0.048
View More